Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2, Zolbetuximab, Ramucirumab, Claudin 18.2 and the tag subtype-page.
Shares CAPOX (capecitabine, oxaliplatin), FOLFOX (5-FU, leucovorin, oxaliplatin), Nivolumab, Pembrolizumab and the tag subtype-page.
Shares CAPOX (capecitabine, oxaliplatin), FOLFOX (5-FU, leucovorin, oxaliplatin), Pembrolizumab and the tag subtype-page.
Shares Paclitaxel / nab-paclitaxel, Pembrolizumab and the tag subtype-page.
Shares Paclitaxel / nab-paclitaxel, Pembrolizumab and the tag subtype-page.
Shares Nivolumab, Pembrolizumab and the tag subtype-page.
Shares Paclitaxel / nab-paclitaxel, Nivolumab, Pembrolizumab and the tag subtype-page.
Shares CAPOX (capecitabine, oxaliplatin), FOLFOX (5-FU, leucovorin, oxaliplatin) and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.